Delivery Order SPE2DB20D2014-SPE2DB24FC56F

Award Date 7/23/24
Potential Completion Date 7/24/24
Potential Value $9.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,566,178,053 units of Valsartan-HCTZ 160-12.5 mg tablets in 90-count bottles. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The delivery order has a ceiling value of $3,327.84 and a completion date of October 23, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $20,952.43 and is a firm fixed price delivery order with a completion date of May 28, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set-aside and is an open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $9,340.11 and is a firm fixed-price delivery order with a completion date of February 5, 2024. This contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug...
The U.S. Defense Logistics Agency (DLA) awarded a $6,894.05 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,062,501 units of Valsartan-HCTZ 320-12.5 mg tablets. The contract has an ultimate completion date of January 29, 2025. This contract is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This contract award from the Defense Logistics Agency (DLA) is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets to the government. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $4,106.77 and an ultimate completion date of January 6, 2022. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award is for the delivery of Valsartan-HCTZ 160-12.5 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $7,725.05. The contract is a delivery order, with a firm fixed-price pricing type, and has an ultimate completion date of September 23, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,422.27 firm-fixed-price delivery order is for the supply of 4,568,185,962 units of the medication Valsartan-HCTZ 160-12.5 mg tablets. The contract has an ultimate completion date of May 9, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open...
This federal contract award, valued at $8,434.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valsartan-Hctz 160-12.5 mg tablets in quantities of 90 per bottle. This is a firm fixed-price delivery order contract with a completion date of May 24, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,985.62, is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 7, 2025. It is not associated with any set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Valsartan-HCTZ 160-12.5 mg tablets. The $5,218.36 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on September 4, 2024, with a completion date of September 5, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC56F
    Delivery Order

The federal contract award is for the delivery of Valsartan-HCTZ 80-12.5 mg tablets, with a ceiling value of $9,807.11 and a completion date of July 24, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that is registered in the System for Award Management (SAM.gov). The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that supports the U.S. military's medical needs. The contract is a delivery order, with a firm fixed price pricing type, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 9:57 AM